Jacqueline Johnson

JACQUELINE JOHNSON, PhD, is President and Chief Executive Officer and
Founder of FeRx Incorporated. Prior to FeRx, she was a Founder and VP
Operations/Business Development of both Signal Pharmaceuticals and
Digital Gene Technologies. Dr. Johnson was earlier Director of Product
Development at Amylin Pharmaceuticals, following a position as Staff
Scientist at Hybritech, Inc. She is a graduate of the University of
California, Berkeley, received her PhD in Genetics from Stanford
University and was a post doctoral fellow at The Salk Institute for
Biological Sciences.